Literature DB >> 6600250

The effect of alpha 1 antitrypsin on the proliferative response of human peripheral blood lymphocytes.

S N Breit, E Luckhurst, R Penny.   

Abstract

In evaluating immune aberrations in patients with alpha 1 antitrypsin (alpha 1 AT) deficiency, we have previously shown that they exhibit enhanced lymphocyte responsiveness to PHA that is serum mediated. In this study, we demonstrate suppression of the PHA response by using purified alpha 1 AT, and also similar but less marked suppression of the Con A response. alpha 1 AT, however, has no effect whatsoever on PWM-induced proliferation. This effect is demonstrable provided alpha 1 AT is added within 4 hr of mitogen activation and is mediated by its action on adherent cells rather than on proliferating lymphocytes. Adherent cells still exhibit this effect if pulsed with alpha 1 AT, then thoroughly washed before their activation. This suggests that it may be inhibiting a membrane serine esterase already activated before the addition of PHA. Thus alpha 1 AT may modulate the activation of T cells through its effect on monocytes, leading to abnormalities in immunoregulation, and hence a predisposition to the development of a variety of immunologic disorders in alpha 1 AT-deficient subjects.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6600250

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Inhibition of lymphocyte DNA synthesis by plasma from patients with Kawasaki disease.

Authors:  J Hirao; N Izumi; Y Nagai; N Homma
Journal:  Eur J Pediatr       Date:  1986-12       Impact factor: 3.183

2.  Prostaglandin E2 and collagenase production by fibroblasts and synovial cells is regulated by urine-derived human interleukin 1 and inhibitor(s).

Authors:  J F Balavoine; B de Rochemonteix; K Williamson; P Seckinger; A Cruchaud; J M Dayer
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

3.  Variants of alpha 1-proteinase inhibitor in black and white South African patients with focal glomerulosclerosis and minimal change nephrotic syndrome.

Authors:  A C Halkas; M C Gaillard; P D Thomson; S L Green; H Ludewick; U Kala
Journal:  J Med Genet       Date:  1998-01       Impact factor: 6.318

4.  Curative and beta cell regenerative effects of alpha1-antitrypsin treatment in autoimmune diabetic NOD mice.

Authors:  Maria Koulmanda; Manoj Bhasin; Lauren Hoffman; Zhigang Fan; Andi Qipo; Hang Shi; Susan Bonner-Weir; Prabhakar Putheti; Nicolas Degauque; Towia A Libermann; Hugh Auchincloss; Jeffrey S Flier; Terry B Strom
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-13       Impact factor: 11.205

5.  Identification of a specific interleukin 1 inhibitor in the urine of febrile patients.

Authors:  Z Liao; R S Grimshaw; D L Rosenstreich
Journal:  J Exp Med       Date:  1984-01-01       Impact factor: 14.307

6.  Cytogenetic study of Ascaris trypsin inhibitor in cultured human lymphocytes with metabolic activation.

Authors:  Joanna Blaszkowska; Wanda Bratkowska; Dobroslawa Lopaczynska; Tomasz Ferenc
Journal:  J Genet       Date:  2009-04       Impact factor: 1.166

7.  Lymphocyte cytotoxicity to autologous hepatocytes in alpha 1-antitrypsin deficiency.

Authors:  M Mondelli; G Mieli-Vergani; A L Eddleston; R Williams; A P Mowat
Journal:  Gut       Date:  1984-10       Impact factor: 23.059

Review 8.  Immunologic mechanisms of parenchymal lung injury.

Authors:  W F Willoughby; J B Willoughby
Journal:  Environ Health Perspect       Date:  1984-04       Impact factor: 9.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.